353 related articles for article (PubMed ID: 27184366)
21. Is pyrazinamide bactericidal against Mycobacterium tuberculosis?
Heifets LB; Lindholm-Levy PJ
Am Rev Respir Dis; 1990 Jan; 141(1):250-2. PubMed ID: 2105072
[TBL] [Abstract][Full Text] [Related]
22. New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.
Heifets L; Sanchez T
J Clin Microbiol; 2000 Apr; 38(4):1498-501. PubMed ID: 10747133
[TBL] [Abstract][Full Text] [Related]
23. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
Lee KW; Lee JM; Jung KS
J Korean Med Sci; 2001 Oct; 16(5):537-43. PubMed ID: 11641519
[TBL] [Abstract][Full Text] [Related]
24. [Pyrazinamide monoresistant Mycobacterium tuberculosis in Manisa region, Turkey].
Ozkütük N; Ecemiş T; Sürücüoğlu S
Mikrobiyol Bul; 2008 Oct; 42(4):585-90. PubMed ID: 19149079
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.
Aragón LM; Garrigó M; Moreno C; Español M; Coll P
J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155
[TBL] [Abstract][Full Text] [Related]
26. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
Zhang Y; Scorpio A; Nikaido H; Sun Z
J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680
[TBL] [Abstract][Full Text] [Related]
27. [A study of the bacteriophage-based assay for the detection of pyrazinamide resistance in Mycobacterium tuberculosis].
Ao JP; Chen JW; Hu ZY; Li JN; Wang J; Wang Q; Cui ZL; Zhang WH; Wong XH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):625-8. PubMed ID: 17129472
[TBL] [Abstract][Full Text] [Related]
28. Rapid colorimetric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
Li H; Zhou LP; Luo J; Yu JP; Yang H; Wei HP
Int J Tuberc Lung Dis; 2016 Apr; 20(4):462-7. PubMed ID: 26970154
[TBL] [Abstract][Full Text] [Related]
29. Pyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature.
den Hertog AL; Menting S; Pfeltz R; Warns M; Siddiqi SH; Anthony RM
Antimicrob Agents Chemother; 2016 Aug; 60(8):4956-60. PubMed ID: 27270287
[TBL] [Abstract][Full Text] [Related]
30. Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test.
Gokarn K; Pal RB
BMC Complement Altern Med; 2017 Mar; 17(1):161. PubMed ID: 28327117
[TBL] [Abstract][Full Text] [Related]
31. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
Doustdar F; Khosravi AD; Farnia P
Microb Drug Resist; 2009 Dec; 15(4):251-6. PubMed ID: 19857130
[TBL] [Abstract][Full Text] [Related]
32. A whole blood bactericidal assay for tuberculosis.
Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
[TBL] [Abstract][Full Text] [Related]
33. 1,25(OH)2-vitamin D3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macrophages.
Crowle AJ; Salfinger M; May MH
Am Rev Respir Dis; 1989 Feb; 139(2):549-52. PubMed ID: 2492412
[TBL] [Abstract][Full Text] [Related]
34. Re-growth of
Hendon-Dunn CL; Pertinez H; Marriott AAN; Hatch K; Allnutt JC; Davies G; Bacon J
Antimicrob Agents Chemother; 2019 Sep; 63(12):. PubMed ID: 31527023
[TBL] [Abstract][Full Text] [Related]
35. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH
Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128
[TBL] [Abstract][Full Text] [Related]
36. Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.
Wade MM; Zhang Y
J Med Microbiol; 2004 Aug; 53(Pt 8):769-773. PubMed ID: 15272064
[TBL] [Abstract][Full Text] [Related]
37. Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
Lanoix JP; Betoudji F; Nuermberger E
Antimicrob Agents Chemother; 2016 Feb; 60(2):1091-6. PubMed ID: 26643352
[TBL] [Abstract][Full Text] [Related]
38. Comparison and development of pyrazinamide susceptibility testing methods for tuberculosis in Thailand.
Foongladda S; Klayut W; Pholwat S; Houpt E
Diagn Microbiol Infect Dis; 2015 Nov; 83(3):270-3. PubMed ID: 26298819
[TBL] [Abstract][Full Text] [Related]
39. Delamanid Kills Dormant Mycobacteria
Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro.
Mashele SA; Steel HC; Matjokotja MT; Rasehlo SSM; Anderson R; Cholo MC
J Glob Antimicrob Resist; 2022 Jun; 29():343-352. PubMed ID: 35339735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
